Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids

Purpose: The purpose of this study was to evaluate the chemical stability of Lincocin® (lincomycin hydrochloride) in commonly used intravenous fluids at room temperature (25°C), at accelerated-degradation temperatures and in selected buffer solutions. Materials and methods: The stability of Lincocin...

Full description

Bibliographic Details
Main Authors: Czarniak, Petra, Boddy, M., Sunderland, Bruce, Hughes, Jeff
Format: Journal Article
Published: Dove Medical Press Ltd. 2016
Online Access:http://hdl.handle.net/20.500.11937/31267
_version_ 1848753330416779264
author Czarniak, Petra
Boddy, M.
Sunderland, Bruce
Hughes, Jeff
author_facet Czarniak, Petra
Boddy, M.
Sunderland, Bruce
Hughes, Jeff
author_sort Czarniak, Petra
building Curtin Institutional Repository
collection Online Access
description Purpose: The purpose of this study was to evaluate the chemical stability of Lincocin® (lincomycin hydrochloride) in commonly used intravenous fluids at room temperature (25°C), at accelerated-degradation temperatures and in selected buffer solutions. Materials and methods: The stability of Lincocin® injection (containing lincomycin 600 mg/2 mL as the hydrochloride) stored at 25°C±0.1°C in sodium lactate (Hartmann’s), 0.9% sodium chloride, 5% glucose, and 10% glucose solutions was investigated over 31 days. Forced degradation of Lincocin® in hydrochloric acid, sodium hydroxide, and hydrogen peroxide was performed at 60°C. The effect of pH on the degradation rate of lincomycin hydrochloride stored at 80°C was determined. Results: Lincomycin hydrochloride was found to maintain its shelf life at 25°C in sodium lactate (Hartmann’s) solution, 0.9% sodium chloride solution, 5% glucose solution, and 10% glucose solution, with less than 5% lincomycin degradation occurring in all intravenous solutions over a 31-day period. Lincomycin hydrochloride showed less rapid degradation at 60°C in acid than in basic solution, but degraded rapidly in hydrogen peroxide. At all pH values tested, lincomycin followed first-order kinetics. It had the greatest stability near pH 4 when stored at 80°C (calculated shelf life of 4.59 days), and was least stable at pH 2 (calculated shelf life of 0.38 days). Conclusion: Lincocin® injection was chemically found to have a shelf life of at least 31 days at 25°C when added to sodium lactate (Hartmann’s) solution, 0.9% sodium chloride solution, 5% glucose solution, and 10% glucose solution. Solutions prepared at approximately pH 4 are likely to have optimum stability.
first_indexed 2025-11-14T08:22:48Z
format Journal Article
id curtin-20.500.11937-31267
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T08:22:48Z
publishDate 2016
publisher Dove Medical Press Ltd.
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-312672017-09-13T15:56:35Z Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids Czarniak, Petra Boddy, M. Sunderland, Bruce Hughes, Jeff Purpose: The purpose of this study was to evaluate the chemical stability of Lincocin® (lincomycin hydrochloride) in commonly used intravenous fluids at room temperature (25°C), at accelerated-degradation temperatures and in selected buffer solutions. Materials and methods: The stability of Lincocin® injection (containing lincomycin 600 mg/2 mL as the hydrochloride) stored at 25°C±0.1°C in sodium lactate (Hartmann’s), 0.9% sodium chloride, 5% glucose, and 10% glucose solutions was investigated over 31 days. Forced degradation of Lincocin® in hydrochloric acid, sodium hydroxide, and hydrogen peroxide was performed at 60°C. The effect of pH on the degradation rate of lincomycin hydrochloride stored at 80°C was determined. Results: Lincomycin hydrochloride was found to maintain its shelf life at 25°C in sodium lactate (Hartmann’s) solution, 0.9% sodium chloride solution, 5% glucose solution, and 10% glucose solution, with less than 5% lincomycin degradation occurring in all intravenous solutions over a 31-day period. Lincomycin hydrochloride showed less rapid degradation at 60°C in acid than in basic solution, but degraded rapidly in hydrogen peroxide. At all pH values tested, lincomycin followed first-order kinetics. It had the greatest stability near pH 4 when stored at 80°C (calculated shelf life of 4.59 days), and was least stable at pH 2 (calculated shelf life of 0.38 days). Conclusion: Lincocin® injection was chemically found to have a shelf life of at least 31 days at 25°C when added to sodium lactate (Hartmann’s) solution, 0.9% sodium chloride solution, 5% glucose solution, and 10% glucose solution. Solutions prepared at approximately pH 4 are likely to have optimum stability. 2016 Journal Article http://hdl.handle.net/20.500.11937/31267 10.2147/DDDT.S94710 Dove Medical Press Ltd. fulltext
spellingShingle Czarniak, Petra
Boddy, M.
Sunderland, Bruce
Hughes, Jeff
Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids
title Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids
title_full Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids
title_fullStr Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids
title_full_unstemmed Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids
title_short Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids
title_sort stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids
url http://hdl.handle.net/20.500.11937/31267